Lab Publication: Advancing Targeted Therapies for HER2-Positive Breast Cancer

 😊  Very proud to share our new article published in J. Med. Chem!
🎓 We showed the interest of one of our new linker technologies allowing the production of high-performance loaded immunoconjugates which present improved plasma stability and internalization within cancer cells compared to the Gold Standard T-DXd.

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *